Serum TNF-related weak inducer of apoptosis (TWEAK) and TNF-related apoptosis-inducing ligand (TRAIL) levels of patients with bipolar disorder in manic episode, in remission and healthy controls
Psychiatry Research Aug 24, 2017
Yirün MC, et al. – This studyÂs objective was to detect serum TNF–related weak inducer of apoptosis (TWEAK) and TNF–related apoptosis–inducing ligand (TRAIL) levels of patients with bipolar disorder and healthy controls. Results of this study suggested that TWEAK was found to be reduced in bipolar patients both for manic episode and remission.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
